Methotrexate for Severe Childhood Atopic Dermatitis: Clinical Experience in a Tertiary Center.

Methotrexate appears to be an effective, safe treatment for severe pediatric AD. Its therapeutic effects continue beyond the medium-term treatment period, as reflected by further improvement in IGA and CDLQI scores in patients who continued methotrexate therapy beyond 10 months.